These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 38035462)
21. Utility of nasal swabs for assessing mucosal immune responses towards SARS-CoV-2. Roubidoux EK; Brigleb PH; Vegesana K; Souquette A; Whitt K; Freiden P; ; Green A; Thomas PG; McGargill MA; Wolf J; Schultz-Cherry S Sci Rep; 2023 Oct; 13(1):17820. PubMed ID: 37857783 [TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2-neutralizing humoral IgA response occurs earlier but modest and diminishes faster compared to IgG response. Takamatsu Y; Omata K; Shimizu Y; Kinoshita-Iwamoto N; Terada M; Suzuki T; Morioka S; Uemura Y; Ohmagari N; Maeda K; Mitsuya H bioRxiv; 2022 Jun; ():. PubMed ID: 35702154 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of the systemic and mucosal immune response induced by COVID-19 and the BNT162b2 mRNA vaccine for SARS-CoV-2. Nickel O; Rockstroh A; Wolf J; Landgraf S; Kalbitz S; Kellner N; Borte M; Pietsch C; Fertey J; Lübbert C; Ulbert S; Borte S PLoS One; 2022; 17(10):e0263861. PubMed ID: 36256664 [TBL] [Abstract][Full Text] [Related]
24. BNT162b2 Vaccination Elicits Strong Serological Immune Responses Against SARS-CoV-2 Including Variants of Concern in Elderly Convalescents. Jahrsdörfer B; Fabricius D; Scholz J; Ludwig C; Grempels A; Lotfi R; Körper S; Adler G; Schrezenmeier H Front Immunol; 2021; 12():743422. PubMed ID: 34659239 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of the accuracy in the mucosal detection of anti-SARS-CoV-2 antibodies in nasal secretions and saliva. Fiorelli D; Francavilla B; Magrini A; Di Girolamo S; Bernardini S; Nuccetelli M Int Immunopharmacol; 2023 Feb; 115():109615. PubMed ID: 36563531 [TBL] [Abstract][Full Text] [Related]
26. Use of a point-of-care test to rapidly assess levels of SARS-CoV-2 nasal neutralising antibodies in vaccines and breakthrough infected individuals. Tan CW; Lim CK; Prestedge J; Batty M; Mah YY; O'Han M; Wang LF; Kilby D; Anderson DE Sci Rep; 2023 Nov; 13(1):20263. PubMed ID: 37985674 [TBL] [Abstract][Full Text] [Related]
27. Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection. Fröberg J; Diavatopoulos DA Curr Opin Infect Dis; 2021 Jun; 34(3):181-186. PubMed ID: 33899752 [TBL] [Abstract][Full Text] [Related]
28. Enhanced SARS-CoV-2 neutralization by dimeric IgA. Wang Z; Lorenzi JCC; Muecksch F; Finkin S; Viant C; Gaebler C; Cipolla M; Hoffmann HH; Oliveira TY; Oren DA; Ramos V; Nogueira L; Michailidis E; Robbiani DF; Gazumyan A; Rice CM; Hatziioannou T; Bieniasz PD; Caskey M; Nussenzweig MC Sci Transl Med; 2021 Jan; 13(577):. PubMed ID: 33288661 [TBL] [Abstract][Full Text] [Related]
29. Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection. Sheikh-Mohamed S; Isho B; Chao GYC; Zuo M; Cohen C; Lustig Y; Nahass GR; Salomon-Shulman RE; Blacker G; Fazel-Zarandi M; Rathod B; Colwill K; Jamal A; Li Z; de Launay KQ; Takaoka A; Garnham-Takaoka J; Patel A; Fahim C; Paterson A; Li AX; Haq N; Barati S; Gilbert L; Green K; Mozafarihashjin M; Samaan P; Budylowski P; Siqueira WL; Mubareka S; Ostrowski M; Rini JM; Rojas OL; Weissman IL; Tal MC; McGeer A; Regev-Yochay G; Straus S; Gingras AC; Gommerman JL Mucosal Immunol; 2022 May; 15(5):799-808. PubMed ID: 35468942 [TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin. Volk A; Covini-Souris C; Kuehnel D; De Mey C; Römisch J; Schmidt T BioDrugs; 2022 Jan; 36(1):41-53. PubMed ID: 34843105 [TBL] [Abstract][Full Text] [Related]
31. Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine. Azzi L; Dalla Gasperina D; Veronesi G; Shallak M; Maurino V; Baj A; Gianfagna F; Cavallo P; Dentali F; Tettamanti L; Maggi F; Maffioli LS; Tagliabue A; Accolla RS; Forlani G EBioMedicine; 2023 Feb; 88():104435. PubMed ID: 36628844 [TBL] [Abstract][Full Text] [Related]
32. Recombinant neutralizing secretory IgA antibodies for preventing mucosal acquisition and transmission of SARS-CoV-2. Göritzer K; Groppelli E; Grünwald-Gruber C; Figl R; Ni F; Hu H; Li Y; Liu Y; Hu Q; Puligedda RD; Jung JW; Strasser R; Dessain S; Ma JK Mol Ther; 2024 Mar; 32(3):689-703. PubMed ID: 38268188 [TBL] [Abstract][Full Text] [Related]
33. Detection of anti-SARS-CoV-2 antibodies in tears: Ocular surface immunity to COVID-19. Guemes-Villahoz N; Burgos-Blasco B; Echevarria-Torres PL; Vidal-Villegas B; Rodriguez de la Peña A; Diaz-Valle D; Fernández-Vigo JI; Sánchez-Ramón S; Garcia-Feijoo J Arch Soc Esp Oftalmol (Engl Ed); 2023 Jul; 98(7):397-403. PubMed ID: 37247663 [TBL] [Abstract][Full Text] [Related]
34. Intramuscular vaccination against SARS-CoV-2 transiently induces neutralizing IgG rather than IgA in the saliva. Winklmeier S; Rübsamen H; Özdemir C; Wratil PR; Lupoli G; Stern M; Schneider C; Eisenhut K; Ho S; Wong HK; Taskin D; Petry M; Weigand M; Eichhorn P; Foesel BU; Mader S; Keppler OT; Kümpfel T; Meinl E Front Immunol; 2024; 15():1330864. PubMed ID: 38375482 [TBL] [Abstract][Full Text] [Related]
36. Comparison of the mucosal and systemic antibody responses in Covid-19 recovered patients with one dose of mRNA vaccine and unexposed subjects with three doses of mRNA vaccines. Liu S; Tsun JGS; Fung GPG; Lui GCY; Chan KYY; Chan PKS; Chan RWY Front Immunol; 2023; 14():1127401. PubMed ID: 36793736 [TBL] [Abstract][Full Text] [Related]
37. Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections. Selva KJ; Ramanathan P; Haycroft ER; Reynaldi A; Cromer D; Tan CW; Wang LF; Wines BD; Hogarth PM; Downie LE; Davis SK; Purcell RA; Kent HE; Juno JA; Wheatley AK; Davenport MP; Kent SJ; Chung AW JCI Insight; 2023 Sep; 8(18):. PubMed ID: 37737263 [TBL] [Abstract][Full Text] [Related]
38. Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program. Wendel S; Kutner JM; Machado R; Fontão-Wendel R; Bub C; Fachini R; Yokoyama A; Candelaria G; Sakashita A; Achkar R; Hamerschlak N; Scuracchio P; Amaral M; Dal Ben M; Araujo D; Soares C; Camargo A; Kallás E; Durigon E; Reis LF; Rizzo LV Transfusion; 2020 Dec; 60(12):2938-2951. PubMed ID: 32935877 [TBL] [Abstract][Full Text] [Related]
39. A nasal vaccine with inactivated whole-virion elicits protective mucosal immunity against SARS-CoV-2 in mice. Tokunoh N; Tamiya S; Watanabe M; Okamoto T; Anindita J; Tanaka H; Ono C; Hirai T; Akita H; Matsuura Y; Yoshioka Y Front Immunol; 2023; 14():1224634. PubMed ID: 37720231 [TBL] [Abstract][Full Text] [Related]